Healthcare
CVS Health Corp. (CVS)
Data as of July 7, 2026
Environment story
Provided filings contain no disclosed Scope 1, Scope 2, or Scope 3 emissions figures and no specified net-zero target year, triggering deductions for non-disclosure under the scoring rubric. The 10-K acknowledges risk that the company 'may be unable to achieve our corporate responsibility and sustainability goals,' but does not quantify emissions baselines, renewable electricity procurement, or offset reliance. The proxy references a 'Healthy 2030' strategy with an environmental imperative and a board Executive Committee chair (Joyner) also chairing that oversight function, but no operational decarbonization metrics are provided in these sources. No specific toxic-waste, water-consumption, or habitat controversies are documented in the supplied materials.
Criticisms on file
No material criticisms on file for this pillar.
Disclosed initiatives
-
Healthy 2030 Strategy - Environmental ImperativeProxy statement references a 'Healthy 2030' strategic framework encompassing economic, environmental, and social imperatives, discussed with stockholders during 2025-2026 engagement sessions.
Social story
Supplied documents do not disclose a numeric CEO-to-median-worker pay ratio (though a 'CEO Pay Ratio' section exists in the proxy table of contents, the figure itself was not extracted), leadership/board diversity percentages, turnover rates, or supply-chain human-rights audit findings. No documented union-suppression activity, NLRB complaints, or major strikes within the last 24 months appear in these sources. Absent verified adverse data, no rubric deductions are applied; this reflects a data gap rather than a confirmed positive assessment.
Criticisms on file
No material criticisms on file for this pillar.
Disclosed initiatives
-
Healthy 2030 Strategy - Social ImperativeProxy references colleague well-being, development, and community health initiatives under the Healthy 2030 framework; specifics and metrics not detailed in provided text.
Governance story
CVS Health maintains a single-class common stock structure with no supermajority or dual-class founder voting rights disclosed. Board independence stands at approximately 84.6% (11 of 13 nominees), exceeding the 75% threshold, so no deduction applies there. However, the company discloses multiple active, significant regulatory and legal proceedings — including False Claims Act/qui tam litigation, DOJ/OIG and CMS audits of Medicare Advantage risk-adjustment data, and state lawsuits (Arkansas, Louisiana, North Dakota, Oklahoma) challenging PBM practices — warranting a moderate deduction for active regulatory/fraud-related proceedings. No specific lobbying expenditure figures targeting climate or consumer-protection rollback were disclosed in the supplied text, so no lobbying-related deduction was applied absent verified figures.
Criticisms on file
-
Multiple qui tam / False Claims Act proceedings and CMS/OIG Medicare Advantage risk-adjustment audits, along with state lawsuits challenging PBM business practices in Arkansas, Louisiana, North Dakota, and Oklahoma.Source: CVS_10k.txt
Disclosed initiatives
-
Majority Voting StandardDirectors are elected by majority of votes cast in uncontested elections; nominees not receiving majority support must submit resignation for board consideration.
-
Proxy Access By-lawSince January 2016, stockholders (individually or as a group of up to 20) owning at least 3% of outstanding stock for 3+ years may nominate director candidates for inclusion in Company proxy materials, up to the greater of two nominees or 20% of the board.
-
Formation of Public Policy and External Affairs (PP&EA) CommitteeBoard established a new PP&EA Committee in November 2025 to oversee public policy, political spending, and reputation-management matters, separating this oversight from the Nominating and Corporate Governance Committee.
These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of CVS Health Corp.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open CVS Health Corp. in the app for interactive charts and portfolio building.
Browse Companies · Methodology · Terms of Service · Privacy Policy · Back to Missionomics